| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |